Astonea Labs Share Price | Astonea Labs Stock Screener
ASTONEALAB
Pharmaceuticals
Track Astonea Labs share price live with TickJournal's free stock screener.
Analyse ASTONEALAB price trends and track historical price performance.
Use the Astonea Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Astonea Labs Market Cap
₹286.40 Cr.
ASTONEALAB P/E Ratio (TTM)
-
Astonea Labs P/B Ratio
5.01
EPS (TTM)
₹4.49
Dividend Yield
-
Debt to Equity
3.16
ASTONEALAB 52 Week High
-
Astonea Labs 52 Week Low
-
Operating Margin
-
Profit Margin
-
ASTONEALAB Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹146.00
Total Equity
₹57.00
Astonea Labs Share Price Chart
Screen Astonea Labs share price with an interactive chart. Analyse ASTONEALAB price trends and volatility across different timeframes.
Astonea Labs Company Profile - Fundamental Screener
Screen Astonea Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ASTONEALAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0TG901011
Astonea Labs Balance Sheet Screener
Screen ASTONEALAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 146 | 103 | 81 | 64 | 53 |
| Current Assets | 98 | 71 | 55 | 43 | 31 |
| Fixed Assets | 39 | 25 | 22 | 21 | 21 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 21 | 22 | 21 | 20 | 23 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 57 | 18 | 12 | 8 | 8 |
| Share Capital | 11 | 8 | 8 | 4 | 4 |
| Reserves & Surplus | 47 | 11 | 4 | 4 | 4 |
Astonea Labs Income Statement Screener - Profit & Revenue Analysis
Screen Astonea Labs income statement and profit fundamentals.
Analyze ASTONEALAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Astonea Labs share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|---|
| Revenue | 0 | 148 | 98 | 80 | 67 | 30 |
| Expenses | 0 | 134 | 82 | 68 | 60 | 24 |
| EBITDA | 0 | 13 | 15 | 12 | 7 | 6 |
| Operating Profit % | 0.00% | 9.00% | 16.00% | 15.00% | 11.00% | 19.00% |
| Depreciation | 0 | 5 | 5 | 4 | 4 | 4 |
| Interest | 0 | 3 | 4 | 3 | 2 | 2 |
| Profit Before Tax | 0 | 6 | 7 | 5 | 1 | 1 |
| Tax | 0 | 2 | 2 | 1 | 0 | 0 |
| Net Profit | 0 | 4 | 5 | 4 | 1 | 0 |
| EPS | 0.00 | 4.49 | 6.94 | 5.36 | 0.88 | 0.33 |
Astonea Labs Cash Flow Screener - Liquidity Fundamentals
Screen ASTONEALAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 9 | 8 | -1 | -5 |
| Investing Activities | -11 | -8 | -3 | -3 |
| Financing Activities | 2 | 0 | 4 | 8 |
| Net Cash Flow | 0 | -1 | 0 | 0 |
Astonea Labs Shareholding Pattern Screener
See Astonea Labs shareholding pattern with promoter, FII, and DII holdings.
Check Astonea Labs promoter holding and ownership changes for ASTONEALAB on TickJournal.
| Item | 2026-Mar | 2025-May | 2025-Jun | 2025-Sept | 2024-Aug |
|---|---|---|---|---|---|
| Promoter Holding | 72.30% | 72.30% | 72.30% | 72.30% | 98.43% |
| FII Holding | 0.00% | 0.00% | 8.01% | 2.51% | 0.00% |
| DII Holding | 0.07% | 0.00% | 4.55% | 0.35% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 22.25% | 12.24% | 11.51% | 17.06% | 0.00% |
| Other Holding | 5.38% | 15.45% | 3.62% | 7.77% | 1.57% |
| Shareholder Count | 376 | 36 | 1,014 | 437 | 36 |
Astonea Labs Share Dividend Screener - Share Yield Analysis
Check Astonea Labs dividend history with payout and yield data.
View Astonea Labs dividend details including ex-dates and amounts for ASTONEALAB stock.
Astonea Labs Stock Index Membership
See which indices include Astonea Labs stock.
Check ASTONEALAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE SME IPO
Astonea Labs Market Events Screener - Corporate Actions
Get Astonea Labs corporate actions including splits, bonuses, and buybacks.
Check Astonea Labs stock events that may affect ASTONEALAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 1.56% |
| 2026-03-27 | 2026-03-27 | Extraordinary General Meeting | NA | 1.29% |
| 2025-12-27 | 2025-12-27 | Annual General Meeting | NA | 6.70% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 2.50% |
| 2025-07-11 | 2025-07-11 | Quarterly Result Announcement | NA | 3.94% |
Astonea Labs Competitors Screener - Peer Comparison
Screen ASTONEALAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 465,087 | 40.90 | 61,674 | 12.69% | 11,565 | 68.02 |
| Divis Laboratories | 195,743 | 75.78 | 11,067 | 13.95% | 2,568 | 71.98 |
| Torrent Pharmaceuticals | 189,317 | 79.75 | 13,886 | 20.34% | 2,138 | 66.68 |
| Cipla | 113,922 | 29.97 | 29,045 | 2.24% | 3,870 | 52.50 |
| Zydus Life Science | 112,688 | 22.27 | 27,658 | 17.64% | 5,026 | 58.19 |
| Lupin | 110,591 | 21.47 | 29,039 | 26.75% | 5,356 | 63.60 |
| Mankind Pharma | 104,988 | 54.93 | 14,636 | 14.85% | 1,938 | 60.75 |
| Dr Reddys Laboratories | 99,025 | 24.22 | 35,059 | 3.90% | 4,158 | 32.84 |
| Aurobindo Pharma | 88,286 | 26.21 | 33,385 | 3.21% | 3,376 | 58.93 |
| Laurus Labs | 85,184 | 96.66 | 6,868 | 22.01% | 890 | 67.71 |
Astonea Labs Company Announcements - News Screener
Screen ASTONEALAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-22 | Board Meeting Intimation for Approval Of Audited Consolidated Financial Results For The Financial Year Ended 31.03.2026 And Others. | - |
| 2026-07-21 | Intimation Under Regulation 30-Execution And Registration Of Sale Deed For Sale Of Immovable Properties. | - |
| 2026-07-18 | Successful Completion Of Regulatory Inspection Of Manufacturing Facility By Supreme Board Of Drugs And Medical Appliances (SBDMA) Ministry Of Health And Population Republic Of Yemen. | - |
| 2026-07-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-20 | Submission Of Additional Documents With Reference To Earlier Corporate Announcement Dated 30Th May 2026 And BSEs Communication Regarding Signing Of Financial Results | - |
| 2026-05-30 | Submission Of Half-Yearly Disclosure On Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended | - |
| 2026-05-30 | Statement Of Deviation & Variation For The Half Year Ended 31.03.2026 | - |
| 2026-05-30 | Re-Appointment Of Tax Auditor | - |
| 2026-05-30 | Re-Appointment Of Cost Auditor | - |
| 2026-05-30 | Re-Appointment Of Secretarial Auditor | - |
| 2026-05-30 | Audited Standalone Financial Results For The Half Year And Year Ended 31.03.2026 | - |
| 2026-05-30 | Board Meeting Outcome for Meeting Held On 30Th May 2026 | - |
| 2026-05-25 | Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For The Half Year And Year Ended On 31St March 2026 | - |
| 2026-04-29 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-27 | Intimation Under Regulation 30 Of SEBI LODR (Regulations) 2015- Fire Incident At Manufacturing Facility | - |
| 2026-04-23 | Statement On Redressal Of Investor Grievances/Complaints For The Quarter Ended 31.03.2026 | - |
| 2026-04-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-31 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-03-27 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |
| 2026-03-27 | Approval Of Variation In The Objects Of The Initial Public Offer (IPO) | - |